HBSP (USA)
-
Schon Klinik: Eating Disorder Care
Porter, Michael E.; Stanton, Emma; Hohman, Jessica A.; Stowell, CalebCase HBS-712475-EStrategyThe Schon Klinik is a private, for-profit German hospital group trying to establish itself as a premium health care provider in a competitive German market. The case details Schon Klinik's founding, its early focus on measurement and improvement, and the design and implementation of a system-wide structure for measuring and reporting actual health outcomes. The case details the care cycle for eating disorder patients and highlights the role outco...Starting at €8.20
-
Building a Winning Culture (Spanish version)
Simons, Robert L.; Kindred, NatalieCase HBS-114S05Accounting and ControlThis case illustrates a CEO-led organizational transformation driven by stretch goals, performance measurement, and accountability. When Kasper Rorsted became CEO of Henkel, a Germany-based producer of personal care, laundry, and adhesives products, in 2008, he was determined to transform a corporate culture of "good enough" into one singularly focused on winning in a competitive marketplace. Historically, Henkel was a comfortable, stable place t...Starting at €8.20
-
Measures to Improve Performance (Spanish version)
Simons, Robert L.; Kindred, NatalieCase HBS-117S10Accounting and ControlThe widespread cheating scandal that rocked the Atlanta public school system in 2010 and 2011 illustrates how high-stakes performance pressure, without sufficient risk controls, can drive dangerous behavior. After becoming superintendent of the low-income and academically struggling Atlanta, Georgia school system in 1999, Beverly Hall implemented new measurement systems-many of them derived from business best practices-to motivate and evaluate th...Starting at €8.20
-
Bayer Crop Science
Bell, David E.; McLoughlin, Damien P.; Kindred, Natalie; Barnett, JamesCase HBS-520055-EStrategyIn mid-2019, a year after German conglomerate Bayer Group closed its acquisition of U.S.-based seeds giant Monsanto, the leadership of Bayer's Crop Science division (which absorbed Monsanto) is reflecting on the opportunities ahead. Some observers have questioned Bayer's decision to buy Monsanto, citing potential reputational and financial liabilities; in the last year, Bayer's stock price has suffered. However, the leadership team expects the co...Starting at €8.20